We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Initiate Data-Mining Process for Adverse Event Study
FDA to Initiate Data-Mining Process for Adverse Event Study
March 23, 2005
The FDA plans to roll out a web-based data-mining system this spring to help drug safety reviewers evaluate data from the Adverse Event Reporting System (AERS).